These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 3991152)

  • 1. [Factors affecting the recurrence rate and progression of superficial (Ta-T1) bladder tumors].
    Kondás J
    Orv Hetil; 1985 Mar; 126(10):577-80. PubMed ID: 3991152
    [No Abstract]   [Full Text] [Related]  

  • 2. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Course of superficial carcinoma of bladder (Ta-T1). Apropos of 171 cases].
    Novak R
    J Urol (Paris); 1987; 93(1):21-4. PubMed ID: 3559256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical techniques in invasive bladder cancer.
    Sonoda T; Debruyne FM; Prout GR; Matsuda M; Blandy JP; Hohenfellner R; Keuppens F; Matsumoto K; Ogata J; Whitmore WF
    Prog Clin Biol Res; 1986; 221():133-48. PubMed ID: 3809180
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is partial cystectomy a justified intervention in the treatment of bladder tumors?].
    Filimon C; Novac C; Gheorghiu V; Costache C; Pricop C; Todosi L; Negru I; Suditu N; Caba D; Roznovanu S; Rusu E; Mihaela R
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(1-2):170-3. PubMed ID: 10756749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histopathologic characteristics and clinical behavior of superficial bladder tumors].
    Kolozsy Z; Samodai L; Mohácsi L; Dauda G; Endresz KF
    Orv Hetil; 1990 Feb; 131(6):283-4, 287-9. PubMed ID: 2406685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoma of the bladder: experience of the USC Los Angeles (antireflux nipple according to Ghoneim)].
    Skinner DG
    Chir Ital; 1997; 49(7):9-15. PubMed ID: 9424420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T1 bladder tumors. Can they be considered superficial?].
    el Ouakdi M; Njeh M; Smaoui S; Masmoudi Z; Ayed M; Zmerli S
    J Urol (Paris); 1991; 97(1):33-5. PubMed ID: 2016550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of very large superficial bladder tumours: a 10-year experience.
    Gupta SK; Parr NJ
    Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining prognostic parameters for urothelial tumors of the bladder.
    Bittard M
    Prog Clin Biol Res; 1984; 162A():161-76. PubMed ID: 6483907
    [No Abstract]   [Full Text] [Related]  

  • 13. [Self-catheterizable urinary re-diversion using the appendix for urethral recurrence after ileal neobladder].
    Ushida H; Masuda Y; Yoshida T; Okada Y
    Hinyokika Kiyo; 2008 Nov; 54(11):749-52. PubMed ID: 19068732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
    Al-Ali MA; Kashmoula DM; Haddad LF
    Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
    Stein JP; Penson DF
    BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of stage Ta,T1 and Tis bladder tumors using Calmette-Guérin bacillus vaccine].
    Bretheau D; Lechevallier E; Rossi D; Albert P; de Fromont M; Coulange C
    Prog Urol; 1993; 3(4):608-17. PubMed ID: 8401621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
    Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
    J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Noninvasive bladder tumors (Ta): progression and recurrence].
    Lundbeck F; Fristrup S; Bichel P; Kjaer TB; Vaeth M
    Ugeskr Laeger; 1987 Nov; 149(48):3251-3. PubMed ID: 3433526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.